Dr. Joanna Horobin - 17 Jan 2023 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
$0
Form type
4
Filing time
19 Jan 2023, 15:30:13 UTC
Previous filing
19 Oct 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award +7,526 +48% 23,123 17 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 17, 2023, the Reporting Person was granted 7,526 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date.